CARINO, ADRIANA
 Distribuzione geografica
Continente #
NA - Nord America 3.099
AS - Asia 1.919
EU - Europa 1.414
SA - Sud America 301
Continente sconosciuto - Info sul continente non disponibili 206
AF - Africa 47
OC - Oceania 4
Totale 6.990
Nazione #
US - Stati Uniti d'America 2.983
SG - Singapore 927
IT - Italia 348
CN - Cina 286
IE - Irlanda 279
VN - Vietnam 248
RU - Federazione Russa 233
BR - Brasile 219
HK - Hong Kong 216
FR - Francia 116
DE - Germania 83
GB - Regno Unito 62
SE - Svezia 61
CA - Canada 54
IN - India 48
FI - Finlandia 47
UA - Ucraina 34
PL - Polonia 32
TR - Turchia 31
NL - Olanda 25
MX - Messico 24
AT - Austria 22
BD - Bangladesh 22
JP - Giappone 21
ES - Italia 18
AR - Argentina 17
EC - Ecuador 17
IQ - Iraq 17
KR - Corea 17
ZA - Sudafrica 17
VE - Venezuela 15
SA - Arabia Saudita 13
BE - Belgio 11
LB - Libano 10
MA - Marocco 10
PK - Pakistan 10
CO - Colombia 9
ID - Indonesia 9
UY - Uruguay 9
CH - Svizzera 8
JM - Giamaica 7
PY - Paraguay 7
UZ - Uzbekistan 7
LT - Lituania 6
CL - Cile 5
EG - Egitto 5
NI - Nicaragua 5
PH - Filippine 5
TT - Trinidad e Tobago 5
TW - Taiwan 5
AL - Albania 4
AZ - Azerbaigian 4
CZ - Repubblica Ceca 4
GR - Grecia 4
HN - Honduras 4
IL - Israele 4
MY - Malesia 4
SV - El Salvador 4
CI - Costa d'Avorio 3
HU - Ungheria 3
NO - Norvegia 3
PE - Perù 3
PR - Porto Rico 3
BF - Burkina Faso 2
BG - Bulgaria 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GT - Guatemala 2
JO - Giordania 2
KE - Kenya 2
NZ - Nuova Zelanda 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
RO - Romania 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
AU - Australia 1
BB - Barbados 1
BN - Brunei Darussalam 1
CG - Congo 1
CR - Costa Rica 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
GP - Guadalupe 1
HR - Croazia 1
HT - Haiti 1
KZ - Kazakistan 1
MD - Moldavia 1
ME - Montenegro 1
NP - Nepal 1
PT - Portogallo 1
Totale 6.782
Città #
Singapore 701
Chandler 372
San Jose 324
Dublin 279
Ashburn 246
Hong Kong 215
San Mateo 171
Dong Ket 133
Perugia 126
Santa Clara 115
Council Bluffs 98
Moscow 85
Ann Arbor 84
Boardman 76
Beijing 72
Medford 71
Los Angeles 70
Princeton 70
Altamura 69
Lauterbourg 63
Lawrence 62
Wilmington 61
Andover 46
New York 42
Ho Chi Minh City 36
São Paulo 31
Dallas 27
Orem 25
Warsaw 25
Hanoi 24
The Dalles 24
Munich 22
Saint Petersburg 21
Tokyo 20
Houston 19
Columbus 18
Redmond 17
Brooklyn 16
Chicago 16
Frankfurt am Main 16
Helsinki 16
North Bergen 16
Seoul 16
Des Moines 15
Rome 14
Falls Church 13
Nuremberg 13
Vienna 13
Montreal 12
Redwood City 12
Brussels 11
Chennai 11
Den Haag 11
Phoenix 11
Izmir 10
Johannesburg 10
London 10
Mexico City 10
Norwalk 10
Stockholm 10
Milan 9
San Francisco 9
Shanghai 9
Toronto 9
Ankara 8
Caracas 8
Denver 8
Naples 8
Quito 8
San Paolo di Civitate 8
Amsterdam 7
Boston 7
Guayaquil 7
Manchester 7
Rio de Janeiro 7
Atlanta 6
Calgary 6
Dhaka 6
Florence 6
New Orleans 6
Piscataway 6
Poplar 6
Baghdad 5
Brasília 5
Contagem 5
Dearborn 5
Guangzhou 5
Haiphong 5
Hefei 5
Jacksonville 5
Jeddah 5
Ludhiana 5
Philadelphia 5
Riyadh 5
Seattle 5
Turin 5
Woodbridge 5
Asunción 4
Baku 4
Bexley 4
Totale 4.500
Nome #
The bile acid receptor GPBAR1 regulates the M1/M2 phenotype of intestinal macrophages and activation of gpbar1 rescues mice from murine colitis 159
The bile acid receptor GPBAR1 (TGR5) is expressed in human gastric cancers and promotes epithelial-mesenchymal transition in gastric cancer cell lines 153
A Comprehensive Analysis of Small Heterodimer Partner (SHP) Target Genes in Hepatic Stellate Cells and the Discovery of a New Class of SHP Agonists That Reduces Liver Fibrosis 151
BAR502, a Dual FXR and GPBAR1 Agonist, Reverses Steatosis and Fibrosis in Rodent Model of NASH By Modulating Authophagic Genes 148
Analysis of Gastric Cancer Transcriptome Allows the Identification of Histotype Specific Molecular Signatures With Prognostic Potential 142
BAR 501, a Novel GPBAR1 Ligand, Reverses Intestinal and Liver Inflammatory Models Demonstrating That GPBAR1 Is an Essential Modulator of Innate Immunity in Entero-Hepatic Tissues 137
Agonism for the bile acid receptor GPBAR1 reverses liver and vascular damage in a mouse model of steatohepatitis 132
Serum Bile Acid Levels Before and After Sleeve Gastrectomy and Their Correlation with Obesity-Related Comorbidities 125
The aryl hydrocarbon receptor (AhR) mediates the counter-regulatory effects of pelargonidins in models of inflammation and metabolic dysfunctions 124
Identification of Cysteinyl-leukotriene-receptor 1 antagonists as ligands for the bile acid receptor GPBAR1 122
BAR501, A SELECTIVE GPBAR1 AGONIST, PROMOTES ADIPOSE TISSUE BROWNING AND AUTOPHAGY AND IMPROVES LIPID METABOLISM AND STEATO-HEPATITIS IN MICE FEED A HIGH FAT DIET 118
Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction 116
241 - GPBAR1 (TGR5) is a Modulator of Liver Immunity and Reverses Liver Inflammation in a Mouse Models of Acute Hepatitis 114
Bile Acid Signaling in Inflammatory Bowel Diseases 114
BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis 113
Genetic and Pharmacological Dissection of the Role of Spleen Tyrosine Kinase (Syk) in Intestinal Inflammation and Immune Dysfunction in Inflammatory Bowel Diseases 113
Discovery of ((1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl)ureidyl derivatives as selective non-steroidal agonists of the G-protein coupled bile acid receptor-1 111
The Bile Acid Receptor GPBAR1 Modulates CCL2/CCR2 Signaling at the Liver Sinusoidal/Macrophage Interface and Reverses Acetaminophen-Induced Liver Toxicity 110
Analysis of Oral and Gut Microbiota Composition in Children with Dental Caries by NGS Approaches 109
BAR130, A HYODEOXYCHOLIC ACID DERIVATIVE AS THE FIRST EXAMPLE OF DUAL LXR alpha/GPBAR1 AGONIST 109
Discovery of a Novel Multi-Strains Probiotic Formulation with Improved Efficacy toward Intestinal Inflammation 109
Ursodeoxycholic acid is a GPBAR1 agonist and resets liver/intestinal FXR signaling in a model of diet-induced dysbiosis and NASH 108
Opposite effects of the FXR agonist obeticholic acid on Mafg and Nrf2 mediate the development of acute liver injury in rodent models of cholestasis 108
The bile acid activated receptors GPBAR1 and FXR exert antagonistic effects on autophagy 106
Bile Acids Activated Receptors in Inflammatory Bowel Disease 104
Metabolic variability of a multispecies probiotic preparation impacts on the anti-inflammatory activity 102
Cystathionine gamma-lyase, a H2S-generating enzyme, is a GPBAR1-regulated gene and contributes to vasodilation caused by secondary bile acids 99
Disruption of TFG beta-SMAD3 pathway by the nuclear receptor SHP mediates the antifibrotic activities of BAR704, a novel highly selective FXR ligand 99
Novel Isoxazole Derivatives with Potent FXR Agonistic Activity Prevent Acetaminophen-Induced Liver Injury 99
Bile acids and their receptors in metabolic disorders 99
DISCOVERY OF BAR704, A POTENT AND SELECTIVE FXR AGONIST, THAT PROTECTS AGAINST LIVER FIBROSIS 98
FXR mediates a chromatin looping in the GR promoter thus promoting the resolution of colitis in rodents. 96
GPBAR1 Functions as Gatekeeper for Liver NKT Cells and provides Counterregulatory Signals in Mouse Models of Immune-Mediated Hepatitis 96
Tu1546 – Gpbar1 is a Modulator of Liver Immunity and Its Agonism Reverses Acetaminophen-Induced Hepatotoxicity by Modulating Recruitment of Liver Macrophages 95
GPBAR1 Activation by C6-Substituted Hyodeoxycholane Analogues Protect against Colitis 95
The HIV Matrix Protein p17 promotes the Activation of human hepatic stellate cells through interactions with CXCR2 and Syndecan-2 94
Exploitation of cholane scaffold for the discovery of potent and selective farnesoid X receptor (FXR) and G-protein coupled bile acid receptor 1 (GP-BAR1) ligands 94
Mo2014 – Comparative Effects of Bar502, a Dual Fxr and Gpbar1 Agonist, Obeticholic Acid and Ursodeoxycholic Acid in a Rodent Model of Nash 94
Endocrine activities and adipogenic effects of bisphenol AF and its main metabolite 93
Divergent effectiveness of multispecies probiotic preparations on intestinal microbiota structure depends on metabolic properties 93
Sa1518 – Mechanism of Acute Liver Decompensation Caused by Obeticholic Acid in Cholestasis is Fxr Dependent 93
Epoxide functionalization on cholane side chains in the identification of G-protein coupled bile acid receptor (GPBAR1) selective agonists 93
Gpbar1 agonism promotes a Pgc-1α-dependent browning of white adipose tissue and energy expenditure and reverses diet-induced steatohepatitis in mice 92
Investigation around the Oxadiazole Core in the Discovery of a New Chemotype of Potent and Selective FXR Antagonists 91
Structural insights into Estrogen Related Receptor-β modulation: 4-methylenesterols from Theonella swinhoei sponge as the first example of marine natural antagonists. 90
Impaired Itching Perception in Murine Models of Cholestasis Is Supported by Dysregulation of GPBAR1 Signaling 89
Su1053 - Bar704, a Potent and Selective Fxr Agonist Protects Against Intestinal Fibrosis 89
Introduction of Nonacidic Side Chains on 6-Ethylcholane Scaffolds in the Identification of Potent Bile Acid Receptor Agonists with Improved Pharmacokinetic Properties 85
Tu1738 - The Aryl Hydrocarbon Receptor Mediates Anti-Inflammatory Activities of Natural and Synthetic Pelargonidines in Mouse Models of Colitis 84
Transcriptome Analysis of Dual FXR and GPBAR1 Agonism in Rodent Model of NASH Reveals Modulation of Lipid Droplets Formation 84
Decoding the role of the nuclear receptor SHP in regulating hepatic stellate cells and liver fibrogenesis 82
VARIABILITY IN INDUSTRIAL PRODUCTION AFFECTS PROBIOTICS ACTIVITY: IDENTIFICATION OF BATCHES OF PROBIOTIC VSL#3 THAT INCREASES INTESTINAL PERMEABILITY AND WORSENS COLITIS IN RODENTS 82
Signaling from Intestine to the Host: How Bile Acids Regulate Intestinal and Liver Immunity 82
GPBAR1 (TGR5) LIGATION PROTECTS AGAINST COLITIS DEVELOPMENT BY REGULATING LEUKOCYTE TRAFFINKING AND PROMOTING A IL-10 DEPENDENT SHIFT IN THE M1/M2 PHENOTYPE 80
Targeting Bile Acid Receptors: Discovery of a Potent and Selective Farnesoid X Receptor Agonist as a New Lead in the Pharmacological Approach to Liver Diseases 80
Solomonsterol A, a marine pregnane-X-receptor agonist, attenuates inflammation and immune dysfunction in a mouse model of arthritis. 79
The HIV matrix protein p17 induces hepatic lipid accumulation via modulation of nuclear receptor transcriptoma 77
The crosstalk between gut barrier impairment, mitochondrial dysfunction, and microbiota alterations in people living with HIV 76
Hijacking SARS-CoV-2/ACE2 Receptor Interaction by Natural and Semi-synthetic Steroidal Agents Acting on Functional Pockets on the Receptor Binding Domain 74
The MyoGravity project to study real microgravity effects on human muscle precursor cells and tissue 73
Reversal of Endothelial Dysfunction by GPBAR1 Agonism in Portal Hypertension Involves a AKT/FOXOA1 Dependent Regulation of H2S Generation and Endothelin-1 73
Discovery of Bile Acid Derivatives as Potent ACE2 Activators by Virtual Screening and Essential Dynamics 72
HIV-1 infection is associated with changes in nuclear receptor transcriptome, pro-inflammatory and lipid profile of monocytes 70
The bile acid sensor FXR is required for immune-regulatory activities of TLR-9 in intestinal inflammation 70
GPBAR1 (TGR5) AGONISM REVERSES ENDOTHELIAL DYSFUNCTION AND LIVER INJURY IN A DIETETIC MODEL OF STEATOHEPATITIS 69
Tu1748 - Probiotics Beyond Taxonomy: Evidence that Anti-inflammatory Properties of Live Biotherapeutic Products Require Phenotypic Characterization 68
Investigation on bile acid receptor regulators. Discovery of cholanoic acid derivatives with dual G-protein coupled bile acid receptor 1 (GPBAR1) antagonistic and farnesoid X receptor (FXR) modulatory activity 60
Navigation in bile acid chemical space: Discovery of novel FXR and GPBAR1 ligands 58
Hyodeoxycholic acid derivatives as liver X receptor α and G-protein-coupled bile acid receptor agonists 57
Phallusiasterol C, A New Disulfated Steroid from the Mediterranean Tunicate Phallusia fumigata 56
Inverse Virtual Screening for the rapid re-evaluation of the presumed biological safe profile of natural products. The case of steviol from Stevia rebaudiana glycosides on farnesoid X receptor (FXR) 56
Insights on FXR selective modulation. Speculation on bile acid chemical space in the discovery of potent and selective agonists 54
New brominated flame retardants and their metabolites as activators of the pregnane X receptor 51
Totale 6.990
Categoria #
all - tutte 34.260
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.260


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022473 0 0 0 27 19 10 19 171 12 39 86 90
2022/20231.081 76 233 10 94 95 94 2 56 366 3 40 12
2023/2024365 19 43 13 10 6 3 91 16 7 19 86 52
2024/20251.100 14 87 35 43 110 89 75 82 203 74 186 102
2025/20262.432 135 161 143 295 391 231 441 121 224 201 65 24
2026/2027653 64 81 133 375 0 0 0 0 0 0 0 0
Totale 6.990